Assessing the Utility of a Genotype‐Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study
The Journal of Clinical Pharmacology · 2024
DOI: 10.1002/jcph.2461 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von Joy E Obayemi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation, Black or African American, Cytochrome P-450 CYP3A. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Tacrolimus metabolism is heavily influenced by the CYP3A5 genotype, which varies widely among African Americans (AA). We aimed to assess the performance of a published genotype‐informed tacrolimus dosing model in an independent set of adult AA kidney transplant (KTx) recipients. CYP3A5 genotypes were obtained for all AA KTx recipients (n = 232) from 2010 to 2019 who met inclusion criteria at a single transplant center in Philadelphia, Pennsylvania, USA. Medical record data were used to calculate predicted tacrolimus clearance using the published AA KTx dosing equation and two modified iterations. Observed and model‐predicted trough levels were compared at 3 days, 3 months, and 6 months post‐transplant. The mean prediction error at day 3 post‐transplant was 3.05 ng/mL, indicating that the model tended to overpredict the tacrolimus trough. This bias improved over time to 1.36 and 0.78 ng/mL at 3 and 6 months post‐transplant, respectively. Mean absolute prediction error—a marker of model precision—improved with time to 2.33 ng/mL at 6 months. Limiting genotype data in the model decreased bias and improved precision. The bias and precision of the published model improved over time and were comparable to studies in previous cohorts. The overprediction observed by the published model may represent overfitting to the initial cohort, possibly limiting generalizability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
- Penn Transplant Institute, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Medicine, Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
- Department of Surgery, New York University, New York, NY, USA.
ORCID-Profile: Joy E Obayemi, Jennifer Trofe-Clark
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Obayemi, J. E., Callans, L., Nair, N., Gao, H., Gandla, D., Loza, B. L., Gao, S., Mohebnasab, M., Trofe-Clark, J., Jacobson, P., & Keating, B. (2024). Assessing the Utility of a Genotype‐Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2461
Vancouver
Obayemi JE, Callans L, Nair N, Gao H, Gandla D, Loza BL, et al. Assessing the Utility of a Genotype‐Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2461
BibTeX
@article{Obayemi2024,
author = {Obayemi, Joy E and Callans, Lauren and Nair, Nikhil and Gao, Hui and Gandla, Divya and Loza, Bao-Li and Gao, Sarah and Mohebnasab, Maedeh and Trofe-Clark, Jennifer and Jacobson, Pamala and Keating, Brendan},
title = {Assessing the Utility of a Genotype‐Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study},
journal = {The Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1002/jcph.2461}
}
EUVIMED